These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 19962986

  • 21. Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
    Yang HI, Sherman M, Su J, Chen PJ, Liaw YF, Iloeje UH, Chen CJ.
    J Clin Oncol; 2010 May 10; 28(14):2437-44. PubMed ID: 20368541
    [Abstract] [Full Text] [Related]

  • 22. Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy.
    Leung NW, Lai CL, Chang TT, Guan R, Lee CM, Ng KY, Lim SG, Wu PC, Dent JC, Edmundson S, Condreay LD, Chien RN, Asia Hepatitis Lamivudine Study Group.
    Hepatology; 2001 Jun 10; 33(6):1527-32. PubMed ID: 11391543
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The role of serial measurement of serum HBV DNA levels in patients with chronic HBeAg(-) hepatitis B infection: association with liver disease progression. A prospective cohort study.
    Zacharakis G, Koskinas J, Kotsiou S, Tzara F, Vafeiadis N, Papoutselis M, Maltezos E, Sivridis E, Papoutselis K.
    J Hepatol; 2008 Dec 10; 49(6):884-91. PubMed ID: 18674840
    [Abstract] [Full Text] [Related]

  • 25. A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels.
    Yalçin K, Değertekin H, Kokoğlu OF, Ayaz C.
    Turk J Gastroenterol; 2004 Mar 10; 15(1):14-20. PubMed ID: 15264116
    [Abstract] [Full Text] [Related]

  • 26. Dynamics of hepatitis B e antigen index ratio correlate with treatment response in chronic hepatitis B patients.
    Wang CC, Liu CJ, Lai MY, Kao JH, Chen DS.
    Liver Int; 2007 Mar 10; 27(2):235-9. PubMed ID: 17311619
    [Abstract] [Full Text] [Related]

  • 27. Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters.
    Tseng TC, Liu CJ, Su TH, Wang CC, Chen CL, Chen PJ, Chen DS, Kao JH.
    Gastroenterology; 2011 Aug 10; 141(2):517-25, 525.e1-2. PubMed ID: 21672542
    [Abstract] [Full Text] [Related]

  • 28. Presence of hepatitis B virus core promoter mutations pre-seroconversion predict persistent viral replication after HBeAg loss.
    Ferns RB, Naoumov NV, Gilson RJ, Tedder RS.
    J Clin Virol; 2007 Jul 10; 39(3):199-204. PubMed ID: 17526429
    [Abstract] [Full Text] [Related]

  • 29. Spontaneous increases in alanine aminotransferase levels in asymptomatic chronic hepatitis B virus-infected patients.
    Kumar M, Chauhan R, Gupta N, Hissar S, Sakhuja P, Sarin SK.
    Gastroenterology; 2009 Apr 10; 136(4):1272-80. PubMed ID: 19208347
    [Abstract] [Full Text] [Related]

  • 30. Long-term follow-up of children with postnatal immunoprophylaxis failure who were infected with hepatitis B virus surface antigen gene mutant.
    Hsu HY, Chang MH, Ni YH, Jeng YM, Chiang CL, Chen HL, Wu JF, Chen PJ.
    J Infect Dis; 2013 Apr 10; 207(7):1047-57. PubMed ID: 23300165
    [Abstract] [Full Text] [Related]

  • 31. Relationship between viral load and genotypes of hepatitis B virus in children with chronic hepatitis B.
    Oommen PT, Wirth S, Wintermeyer P, Gerner P.
    J Pediatr Gastroenterol Nutr; 2006 Sep 10; 43(3):342-7. PubMed ID: 16954957
    [Abstract] [Full Text] [Related]

  • 32. Characterization of viral kinetics in patients with hepatitis B e antigen-positive chronic hepatitis B.
    Wu IC, Chow NH, Cheng PN, Liu WC, Young KC, Chang WL, Chen CY, Tseng KC, Chang TT.
    J Med Virol; 2007 Jun 10; 79(6):663-9. PubMed ID: 17457902
    [Abstract] [Full Text] [Related]

  • 33. Serum levels of preS antigen (HBpreSAg) in chronic hepatitis B virus infected patients.
    Lian M, Zhou X, Wei L, Qiu S, Zhou T, Li L, Gu X, Luo M, Zheng X.
    Virol J; 2007 Sep 24; 4():93. PubMed ID: 17892580
    [Abstract] [Full Text] [Related]

  • 34. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M, Mutlu B, Erdoğan S, Meriç M, Willke A.
    Mikrobiyol Bul; 2007 Jan 24; 41(1):87-93. PubMed ID: 17427556
    [Abstract] [Full Text] [Related]

  • 35. Significance of hepatitis B genotype in acute exacerbation, HBeAg seroconversion, cirrhosis-related complications, and hepatocellular carcinoma.
    Yuen MF, Sablon E, Yuan HJ, Wong DK, Hui CK, Wong BC, Chan AO, Lai CL.
    Hepatology; 2003 Mar 24; 37(3):562-7. PubMed ID: 12601354
    [Abstract] [Full Text] [Related]

  • 36. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.
    Hsu YS, Chien RN, Yeh CT, Sheen IS, Chiou HY, Chu CM, Liaw YF.
    Hepatology; 2002 Jun 24; 35(6):1522-7. PubMed ID: 12029639
    [Abstract] [Full Text] [Related]

  • 37. A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patients.
    Tseng TC, Liu CJ, Wang CC, Chen PJ, Lai MY, Kao JH, Chen DS.
    Liver Int; 2008 Aug 24; 28(7):1034-41. PubMed ID: 18492018
    [Abstract] [Full Text] [Related]

  • 38. The duration of lamivudine therapy for chronic hepatitis B: cessation vs. continuation of treatment after HBeAg seroconversion.
    Fung J, Lai CL, Tanaka Y, Mizokami M, Yuen J, Wong DK, Yuen MF.
    Am J Gastroenterol; 2009 Aug 24; 104(8):1940-6; quiz 1947. PubMed ID: 19455108
    [Abstract] [Full Text] [Related]

  • 39. e-antigen-negative chronic hepatitis B in Bangladesh.
    Ahmad N, Alam S, Mustafa G, Adnan AB, Baig RH, Khan M.
    Hepatobiliary Pancreat Dis Int; 2008 Aug 24; 7(4):379-82. PubMed ID: 18693173
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.